Personalizing oncology treatments by predicting drug efficacy, side-effects, and improved therapy: mathematics, statistics, and their integration
Author:
Affiliation:
1. Institute for Medical BioMathematics; Hate'ena Bene Ataroth Israel
2. Optimata Ltd.; Zichron Ya'akov; Tel Aviv Israel
Publisher
Wiley
Subject
Biochemistry, Genetics and Molecular Biology (miscellaneous),Medicine (miscellaneous)
Reference66 articles.
1. Prognostic versus predictive value of biomarkers in oncology;Oldenhuis;Eur J Cancer,2008
2. Pharmacodynamic biomarkers for molecular cancer therapeutics;Sarker;Adv Cancer Res,2007
3. Predictive biomarkers: a paradigm shift towards personalized cancer medicine;La Thangue;Nat Rev Clin Oncol,2011
4. Cancer biomarkers: surviving the journey from bench to bedside;Rhea;MLO Med Lab Obs,2011
5. The cancer biomarker problem;Sawyers;Nature,2008
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Personalized tumor combination therapy optimization using the single-cell transcriptome;Genome Medicine;2023-12-01
2. Treatment of evolving cancers will require dynamic decision support;Annals of Oncology;2023-10
3. Multiplicity of Time Scales in Blood Cell Formation and Leukemia;Mathematics Online First Collections;2023
4. Psychosocial and emotional morbidities after a diagnosis of cancer: Qualitative evidence from healthcare professional cancer patients;Nursing Open;2022-12-20
5. Validation of a Mathematical Model Describing the Dynamics of Chemotherapy for Chronic Lymphocytic Leukemia In Vivo;Cells;2022-07-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3